Biologicals: an attempt at classification and its implication for the viral safety of products.
Horaud
F
F
Institut Pasteur, Paris.
D000818:Animals; D001688:Biological Products / Q000009:adverse effects / Q000145:classification*; D002478:Cells, Cultured / Q000382:microbiology; D003140:Communicable Disease Control; D003141:Communicable Diseases / Q000635:transmission*; D007562:Creutzfeldt-Jakob Syndrome / Q000635:transmission; D004340:Drug Contamination; D015658:HIV Infections / Q000635:transmission; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D011994:Recombinant Proteins / Q000009:adverse effects; D012449:Safety; D014020:Tissue Extracts / Q000009:adverse effects; D014611:Vaccination / Q000009:adverse effects; D014765:Viral Vaccines / Q000009:adverse effects; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission
D001688:Biological Products; D011994:Recombinant Proteins; D014020:Tissue Extracts; D014765:Viral Vaccines